Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage (Phenobarbital)
Randomized Clinical Trial of Antenatal Phenobarbital in the Prevention of Neonatal Intracranial Hemorrhage
Sponsor: NICHD Neonatal Research Network
Listed as NCT00009620, this PHASE3 trial focuses on Infant, Low Birth Weight and Infant, Newborn and remains completed. Sponsored by NICHD Neonatal Research Network, it has been updated 8 times since 1993, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Apr 2019 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Completed PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Feb 1993
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NICHD Neonatal Research Network
- National Center for Research Resources (NCRR)
For direct contact, visit the study record on ClinicalTrials.gov .